Trials / Conditions / Chediak-Higashi Syndrome

Chediak-Higashi Syndrome

12 registered clinical trials studyying Chediak-Higashi Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Completed	Bone Marrow Transplant With Abatacept for Non-Malignant Diseases NCT01917708	Emory University	Phase 1
Active Not Recruiting	Immune Disorder HSCT Protocol NCT01821781	Washington University School of Medicine	Phase 2
Active Not Recruiting	Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies NCT01652092	Masonic Cancer Center, University of Minnesota	N/A
Terminated	Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation NCT01319851	Emory University	N/A
Completed	Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells NCT00730314	Children's Hospital Los Angeles	Phase 1 / Phase 2
Recruiting	Study of Chediak-Higashi Syndrome NCT00005917	National Human Genome Research Institute (NHGRI)	—
Completed	Stem Cell Transplant for Immunologic or Histiocytic Disorders NCT00176865	Masonic Cancer Center, University of Minnesota	Phase 2
Terminated	T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders NCT00176826	Masonic Cancer Center, University of Minnesota	Phase 2 / Phase 3
Completed	Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders NCT00005933	National Institute of Allergy and Infectious Diseases (NIAID)	—
Unknown	Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemop NCT00006056	Fairview University Medical Center	N/A
Terminated	Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies NCT00006054	Fairview University Medical Center	N/A